Dr. Lisa Ann Zickuhr, MD

Dr. Zickuhr practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Zickuhr's NPI, 1083978886, was assigned on June 27, 2012. Dr. Zickuhr graduated from Northwestern University Feinberg Medical School in 2012. Dr. Zickuhr holds Missouri license 2014023582.

Dr. Zickuhr's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Zickuhr also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Zickuhr's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Zickuhr is also affiliated with Christian Hospital. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Zickuhr to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zickuhr practices, 5 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Zickuhr's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Zickuhr is licensed in Missouri.

CMS data shows 204 Medicare services from Dr. Zickuhr across 7 procedure codes in 2024, for 173 Medicare patients. Medicare paid $13,421 for them.

CMS counts 173 Medicare patients who saw Dr. Zickuhr in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have arthritis, and 75% have high blood pressure. 27% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zickuhr's median patient age at 63, with 75% women.

In 2024, Dr. Zickuhr wrote 671 Medicare Part D claims for 105 patients. 84% of them were for generic drugs. CMS names the drug for 522 of them, across 15 drugs with 11 or more claims each, at $418,884 in total drug cost. In 2023, CMS named 601 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Zickuhr for performance year 2024, reported as part of a group. Dr. Zickuhr accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 20 papers to Dr. Zickuhr, published from 2012 to 2025. 2023 was the busiest year, with 6. The most frequent topics are Rheumatology, Clinical Competence and Education, Medical, Graduate. Dr. Zickuhr has published most often in Arthritis Care Res (Hoboken). Dr. Zickuhr's most frequent co-authors are Marcy B. Bolster, MD, Jason R. Kolfenbach, MD and Amaad Bashir Rana, MD.

CMS Open Payments shows 22 general payments to Dr. Zickuhr from 6 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 71% of the total. Eli Lilly and Company paid the most, $2,300.

Dr. Zickuhr graduated from Northwestern University Feinberg Medical School in 2012.